Delivery Order SPE2DB20D2104-SPE2DB24FT64Z
Award Date
4/16/24
Potential Completion Date
4/17/24
Potential Value
$7.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,668.33 firm fixed-price delivery order is for the supply of EXFORGE 10-320 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 30, 2025 and was awarded on January 29, 2025. This award is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company and subsidiary of Cencora, Inc. The $7,542.07 firm fixed-price delivery order is for the supply of EXFORGE 5-160 MG TABLET 30S, a cardiovascular medication. The award has an ultimate completion date of July 7, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of EXFORGE 10-320 MG tablet medication. The contract, valued at $4,543.89, is a Firm Fixed Price Delivery Order with a completion date of March 7, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $4,506.85, is for the delivery of EXFORGE 10-320 MG TABLET 30S, a pharmaceutical product. The contract type is a Delivery Order under a Firm Fixed Price pricing arrangement, with a period of performance through May 1, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, as the prime...
This federal contract award, valued at $13,176.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order type with a Firm Fixed Price pricing structure, and has an ultimate completion date of July 12, 2024. The contract provides for the procurement of EXFORGE 10-320 MG TABLET 30S, a pharmaceutical product. This award is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,358.56 firm fixed-price delivery order is for the supply of EXFORGE 5-160 MG TABLET 30S, a cardiovascular medication. The contract has an ultimate completion date of November 1, 2023 and was awarded on October 31, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,167.58 firm fixed-price contract is for the supply of EXFORGE 10-320 MG tablets, with a period of performance through July 1, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of EXFORGE HCT 10-320-25 MG TAB 30S, a cardiovascular medication, under a firm fixed price contract. The contract has a ceiling value of $3,700.46 and an ultimate completion date of February 7, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc.,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,133.10, is a Firm Fixed Price Delivery Order for the supply of EXFORGE 5-160 MG TABLET 30S. The contract has an ultimate completion date of January 14, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,523.65 firm fixed price delivery order is for the supply of EXFORGE 10-320 MG TABLET 30S, a cardiovascular medication. The award is not associated with a set-aside program and has an ultimate completion date of December 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...